CD8A and hydrops fetalis: Together, these data demonstrate that CD8+ T cells play a critical role in HF development and progression in mice with or without Treg dysfunction, indicating that restraining the overreactive CD8+ T cells may be a potential therapeutic target for treating HF progression.